140 related articles for article (PubMed ID: 4383705)
1. Blood pressure and noradrenaline levels after treatment with alpha-methyldopa, alpha-methyldopamine and alpha-methyl-m-tyrosine.
Henning M
J Pharm Pharmacol; 1967 Nov; 19(11):775-9. PubMed ID: 4383705
[No Abstract] [Full Text] [Related]
2. Central hypotensive effect of alpha-methyldopa.
Henning M; van Zwieten PA
J Pharm Pharmacol; 1968 Jun; 20(6):409-17. PubMed ID: 4386523
[No Abstract] [Full Text] [Related]
3. On the role of alpha-methyldopamine in the antihypertensive effect of alpha-methyldopa.
Waldmeier P; Hedwal PR; Maître L
Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(3):303-14. PubMed ID: 169487
[TBL] [Abstract][Full Text] [Related]
4. Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.
Henning M
Acta Pharmacol Toxicol (Copenh); 1969; 27(2):135-48. PubMed ID: 5819569
[No Abstract] [Full Text] [Related]
5. Central hypotensive effect of alpha-methyldopa.
Henning M; Van Zwieten PA
J Pharm Pharmacol; 1967 Jun; 19(6):403-5. PubMed ID: 4382373
[No Abstract] [Full Text] [Related]
6. Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline.
Henning M; Rubenson A
J Pharm Pharmacol; 1971 Jun; 23(6):407-11. PubMed ID: 4397178
[No Abstract] [Full Text] [Related]
7. Central dopamine and noradrenaline receptor activity of the amines formed from m-tyrosine, alpha-methyl-m-tyrosine and alpha-methyldopa.
Andén NE; Butcher SG; Engel J
J Pharm Pharmacol; 1970 Jul; 22(7):548-50. PubMed ID: 4395068
[No Abstract] [Full Text] [Related]
8. Mechanisms of noradrenaline and 5-hydroxytryptamine disappearance induced by alpha-methyl-dopa and alpha-methyl-metatyrosine.
Andén NE; Fuxe K; Henning M
Eur J Pharmacol; 1969 Dec; 8(3):302-9. PubMed ID: 5263681
[No Abstract] [Full Text] [Related]
9. Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system.
Andén NE
Eur J Pharmacol; 1967 Jan; 1(1):1-5. PubMed ID: 6058896
[No Abstract] [Full Text] [Related]
10. Further studies on the mechanism of the central hypotensive effect of L-dopa, DL-m-tyrosine and L-alpha-methyldopa.
Rubenson A
J Pharm Pharmacol; 1971 Mar; 23(3):228-30. PubMed ID: 4396899
[No Abstract] [Full Text] [Related]
11. [On the effect of alpha-methyltyrosine on the noradrenaline content of the heart and on the noradrenaline and dopamine content of the brain in normal and thyroxine pretreated guinea pigs].
Lisch HJ
Klin Wochenschr; 1968 Jul; 46(14):786-8. PubMed ID: 5698726
[No Abstract] [Full Text] [Related]
12. An investigation of alpha-methyl amino-acids and their derivatives on isolated tissue preparations.
Gulati OD; Parikh HM; Ringe SY; Sherlekar ML
Br J Pharmacol; 1970 Dec; 40(4):689-701. PubMed ID: 5495174
[TBL] [Abstract][Full Text] [Related]
13. Liberation of alpha-methyldopamine as a "false" sympathetic transmitter after pretreatment of cats with alpha-methyldopa and disulfiram.
Thoenen H; Haefely W; Gey KF; Hürlmann A
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(2):181-96. PubMed ID: 4385111
[No Abstract] [Full Text] [Related]
14. Studies on the mode of action of alpha-methyldopa.
Henning M
Acta Physiol Scand Suppl; 1969; 322():1-37. PubMed ID: 4311985
[No Abstract] [Full Text] [Related]
15. The effects of peripherally administered 6-hydroxydopamine on rat brain monoamine turnover.
Clark WG; Corrodi H; Masuoka DT
Eur J Pharmacol; 1971 Jun; 15(1):41-4. PubMed ID: 5161339
[No Abstract] [Full Text] [Related]
16. A reliable method for the simultaneous estimation of dopamine, noradrenaline and serotonin in discrete areas of brain.
Butterworth RF; Landreville F; Guitard M; Barbeau A
Clin Biochem; 1975 Oct; 8(5):298-302. PubMed ID: 1201621
[TBL] [Abstract][Full Text] [Related]
17. Central hypotensive effect of alpha-methyldopa.
Henning M; van Zwieten PA
Acta Pharmacol Toxicol (Copenh); 1967; 25():Suppl 4:25. PubMed ID: 5630931
[No Abstract] [Full Text] [Related]
18. Saligenin analogs of l-DOPA and dl-alpha-methyl-DOPA.
Atkinson M; Hartley D; Lunts LH; Ritchie AC
J Med Chem; 1974 Feb; 17(2):248-9. PubMed ID: 4809259
[No Abstract] [Full Text] [Related]
19. The effect of reserpine, alpha-methyl-m-tyrosine, prenylamine, and guanethidine on metrazol-convulsions and the brain monoamine level in mice.
Pfeifer AK; Galambos E
Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):201-11. PubMed ID: 6030237
[No Abstract] [Full Text] [Related]
20. The effects of alpha-methyldopa, reserpine, guanethidine, and iproniazid on minimum alveolar anesthetic requirement (MAC).
Miller RD; Way WL; Eger EI
Anesthesiology; 1968; 29(6):1153-8. PubMed ID: 5726752
[No Abstract] [Full Text] [Related]
[Next] [New Search]
